Weight loss after sleeve gastrectomy in patients with diabetes : preliminary study in one year of activity
OBJECTIVE: The objective of our study is to investigate whether diabetes mellitus could adversely affect post-laparoscopic sleeve gastrectomy (LSG) weight loss.
PATIENTS AND METHODS: A retrospectively recorded database of patients who underwent LSG from September 2018 to September 2019 in our Hospital in L'Aquila was analyzed. The post-operative weight loss was evaluated in terms of body mass index (BMI) variation, percentage of excess weight loss (%EWL) and percentage of total weight loss (%TWL). The association between these parameters and diabetes was analyzed at 3 and 6 months of follow-up.
RESULTS: The two groups (patients with and without diabetes) were considered comparable in terms of anthropometric and preoperative parameters. At 3 and 6 months of follow-up, the decrease in BMI resulted to be directly associated with the time and the group. The mean BMI at 3 and 6 months was higher in patients with diabetes. Changes in % EWL and % TWL were similar in both groups.
CONCLUSIONS: It is rational to expect a lower weight loss in obese diabetic patients after LSG. This should not be considered as a contraindication to bariatric surgery that, being a metabolic surgery, has as main goal the resolution or improvement of co-morbidities.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
---|---|
Enthalten in: |
European review for medical and pharmacological sciences - 25(2021), 12 vom: 06. Juni, Seite 4317-4324 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Romano, L [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 01.03.2022 Date Revised 01.03.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.26355/eurrev_202106_26139 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM327735562 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM327735562 | ||
003 | DE-627 | ||
005 | 20231225201436.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.26355/eurrev_202106_26139 |2 doi | |
028 | 5 | 2 | |a pubmed24n1092.xml |
035 | |a (DE-627)NLM327735562 | ||
035 | |a (NLM)34227066 | ||
035 | |a (PII)26139 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Romano, L |e verfasserin |4 aut | |
245 | 1 | 0 | |a Weight loss after sleeve gastrectomy in patients with diabetes |b preliminary study in one year of activity |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.03.2022 | ||
500 | |a Date Revised 01.03.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: The objective of our study is to investigate whether diabetes mellitus could adversely affect post-laparoscopic sleeve gastrectomy (LSG) weight loss | ||
520 | |a PATIENTS AND METHODS: A retrospectively recorded database of patients who underwent LSG from September 2018 to September 2019 in our Hospital in L'Aquila was analyzed. The post-operative weight loss was evaluated in terms of body mass index (BMI) variation, percentage of excess weight loss (%EWL) and percentage of total weight loss (%TWL). The association between these parameters and diabetes was analyzed at 3 and 6 months of follow-up | ||
520 | |a RESULTS: The two groups (patients with and without diabetes) were considered comparable in terms of anthropometric and preoperative parameters. At 3 and 6 months of follow-up, the decrease in BMI resulted to be directly associated with the time and the group. The mean BMI at 3 and 6 months was higher in patients with diabetes. Changes in % EWL and % TWL were similar in both groups | ||
520 | |a CONCLUSIONS: It is rational to expect a lower weight loss in obese diabetic patients after LSG. This should not be considered as a contraindication to bariatric surgery that, being a metabolic surgery, has as main goal the resolution or improvement of co-morbidities | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Necozione, S |e verfasserin |4 aut | |
700 | 1 | |a Cianca, G |e verfasserin |4 aut | |
700 | 1 | |a Schietroma, M |e verfasserin |4 aut | |
700 | 1 | |a Carlei, F |e verfasserin |4 aut | |
700 | 1 | |a Giuliani, A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European review for medical and pharmacological sciences |d 1997 |g 25(2021), 12 vom: 06. Juni, Seite 4317-4324 |w (DE-627)NLM09387944X |x 2284-0729 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2021 |g number:12 |g day:06 |g month:06 |g pages:4317-4324 |
856 | 4 | 0 | |u http://dx.doi.org/10.26355/eurrev_202106_26139 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 25 |j 2021 |e 12 |b 06 |c 06 |h 4317-4324 |